KARO HEALTHCARE NORGE AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: TL
Thor Linge1967
Chairman of the board: CE
Christoffer Erik Mathies Lorentzen1975
Years since formation: 23 years; since Oct 2, 2001
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 36,472,069; 1 share class
Total number of shareholders: 1; person
Belongs to group of

Financials

Annual total result 2023: 122,607,327; NOK
Total equity 2023: 1,544,204,217; NOK

Last update: Aug 29, 2024

Management

Management / administration

Name	Role	Shares
TL Thor Linge 1967	Managing Director/CEO	-

Board

Name	Role	Shares
CE Christoffer Erik Mathies Lorentzen 1975	Chairman	-
JS Jon Sebastian Jonsson 1975	Board Member	-
LM Lars Magnus Nylen 1974 Resigned	Board Member	-
TL Thor Linge 1967	Board Member	-

Others

Name	Role	Shares
K KPMG AS	Auditor	-
E ECIT NORIAN AS	Accountant	-

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Number of shares	Share
K Karo Healthcare Ab	NO0010308240	36,472,069	100 %

Shares owned by the KARO HEALTHCARE NORGE AS

Name	Share class	Number of shares	Share
K KARO PHARMA AS	Ordinary shares	6,798,000	100 %

Last update: May 24, 2024

Group structure

KARO HEALTHCARE NORGE AS
Total operating income 2023: NOK 0
Operating profit 2023: NOK -311,402
Employees: 0

Financials

in NOK

Summary

Year	2023	2022
Total operating income	0	0
Annual Total Result	122,607,327	99,387,774
Total assets	1,544,254,241	1,446,898,749
Total liabilities	50,025	25,301,859
Total equity	1,544,204,217	1,421,596,890

P&L

Year	2023	2022
Total operating income	0	0
Total operating costs	311,402	166,726
Operating result	-311,402	-166,726
Financial income/costs	157,500,283	127,586,949
Profit before tax	157,188,881	127,420,223
Total tax & extraordinary income/cost	34,581,554	28,032,449
Annual Total Result	122,607,327	99,387,774

Balance overview

Year	2023	2022
Total fixed assets	1,280,403,295	1,314,984,849
Total current assets	263,850,947	131,913,900
Total assets	1,544,254,241	1,446,898,749
Short term debt	50,025	25,301,859
Long term debt	0	0
Total liabilities	50,025	25,301,859
Contributed capital	1,045,149,871	1,045,149,871
Retained earnings	499,054,345	376,447,019
Total equity	1,544,204,217	1,421,596,890
Total equity and liabilities	1,544,254,241	1,446,898,749

KARO HEALTHCARE NORGE AS983 733 506